Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/26/2025

Safe Management of Chronic Neuromuscular Pain

Non-Pharmacological Approaches

  • Cognitive Behavioral Therapy (CBT) is strongly recommended as it promotes patient acceptance of responsibility for change and development of adaptive behaviors while addressing maladaptive behaviors such as avoiding exercise due to fear of pain 1, 4
  • Yoga is recommended specifically for chronic neck/back pain, headache, rheumatoid arthritis, and general musculoskeletal pain, which are common in neuromuscular disorders 2, 5
  • Physical and occupational therapy are recommended to improve muscle strength, function, and reduce pain interference in daily activities 3
  • Medical exercise to improve muscular strength and sensorimotor functions should be offered to patients with neuromuscular pain 6
  • Hypnosis is recommended particularly for neuropathic pain components that may be present in neuromuscular conditions 4
  • Acupuncture may be considered as a trial for chronic pain, though evidence is more limited 7

Pharmacological Management

First-Line Medications

  • Gabapentin is recommended as a first-line oral pharmacological treatment for chronic neuropathic pain components, typically titrated to 2400 mg per day in divided doses 2
  • Capsaicin (8% dermal patch or cream) is recommended as a topical treatment, with a single 30-minute application providing pain relief for up to 12 weeks 3
  • Acetaminophen and NSAIDs are recommended as first-line agents for musculoskeletal pain components [8, @23@]
  • Use lower doses of acetaminophen in patients with liver disease, and consider cardiovascular risk when prescribing COX-2 NSAIDs [@23@, 7]

Second-Line Medications

  • Serotonin-norepinephrine reuptake inhibitors (SNRIs) such as duloxetine or venlafaxine may be considered if inadequate response to first-line treatments 1, 6
  • Tricyclic antidepressants (TCAs) may be considered, though they have more side effects than SNRIs 2, 8
  • Pregabalin may be considered, particularly for neuropathic pain components 3
  • Alpha lipoic acid (ALA) is recommended for neuropathic pain components, with growing evidence for its benefits [7, @19@]

Medications to Avoid or Use with Caution

  • Opioid analgesics should not be prescribed as first-line agents for long-term management of chronic neuromuscular pain due to risks of pronociception, cognitive impairment, respiratory depression, endocrine and immunological changes, and misuse/addiction [@21@, 7]
  • Lamotrigine is not recommended for neuropathic pain due to risk of rash and limited evidence of efficacy [@20@, 1]
  • Benzodiazepines should be used with caution as evidence for their efficacy in chronic pain is limited 8

Special Considerations

  • Regular assessment of pain intensity, functional improvement, and side effects should be implemented for patients prescribed medications, especially if considering a time-limited trial of opioids for refractory pain [@26@, 7]
  • Use of opioid treatment agreements and urine drug testing if opioids are prescribed [@27@, 1]